Clinical Trials Browser

Phase 2 × Breakthrough Pain × Clear all

NCT03809455 2020-04-22

FARADI

Phase 2 Withdrawn

Breakthrough Pain

NCT00236041 2014-05-09

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Phase 2 Completed

Classical hematology

Agnosia, Anemia, Sickle Cell, Burns, Neoplasms, Breakthrough Pain